TGNA (TGNA)

$3.2B
Market Cap
14.9
P/E Ratio
0.12
Beta
0.03%
Dividend Yield
Piotroski 5/9Altman Z 1.9 Gray ZoneBeneish M -2.37 CleanROIC−WACC -0.7%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of the company reveal a capital allocation challenge where operating returns fail to cover the cost of equity, evidenced by an ROIC-WACC spread of -0.7%. This negative spread suggests that current investments are destroying value relative to shareholder expectations. The DuPont decomposition highlights a specific structural weakness: while net margins remain robust at 8.1% and leverage is moderate at 2.18x times, the engine driving returns is severely hampered by an asset turnover ratio of only 0.39x. This inefficiency in utilizing assets to generate sales correlates with significant revenue contraction of -12.6% year-over-year. Although the Beneish M-Score of -2.37 indicates low likelihood of earnings manipulation and the Piotroski F-Score of 5/9 reflects moderate financial strength, the Altman Z-Score of 1.9 signals elevated distress risk that warrants caution regarding long-term solvency under stress scenarios.

Valuation metrics present a dichotomy between current market pricing and intrinsic value estimates derived from discounted cash flow analysis. The stock trades at a P/E multiple of 14.9x, which appears compressed relative to its historical trajectory but must be contextualized against the backdrop of declining top-line growth. A DCF model implies a fair value of $23; however, this valuation is contingent on assumptions regarding future margin expansion and asset efficiency that have not yet materialized in recent periods. The market price likely reflects skepticism about whether management can reverse the negative revenue trend to justify the implied growth rates embedded in the discounting process.

Risk assessment data points toward a precarious balance sheet profile without clear catalysts for near-term improvement. Insider activity over the last 90 days remains neutral, offering no signal of confidence or distress from those closest to operations. While the low Beneish score mitigates concerns regarding fraudulent accounting, the combination of negative free cash flow generation potential (indicated by ROIC < WACC) and a Z-Score approaching bankruptcy territory suggests significant downside volatility if revenue deterioration continues. Investors must weigh the attractive entry multiple against the substantial operational headwinds and solvency risks inherent in the current business model.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%6.2%8.2%
2%$18$16$7
3%$26$23$10
4%$43$38$14

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=6.2%, terminal growth 3%. Fair value $23 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.9
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.37
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

36.2%
Gross Margin
8.1%
Net Margin
5.5%
ROIC
6.2%
WACC
ROIC − WACC Spread: -0.7%— Negative spread.
-12.6%
Revenue Growth (YoY)
-63.3%
Earnings Growth (YoY)
282.6M
Free Cash Flow
28%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

8.1%
Net Profit Margin
NI ÷ Revenue
×
0.39x
Asset Turnover
Revenue ÷ Assets
×
2.18x
Equity Multiplier
Assets ÷ Equity
=
7.0%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.18x
Debt / Equity
2.28x
Current Ratio
2.8x
Interest Coverage
4.1x
Net Debt / EBITDA
5.15%
FCF Yield
544.2M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.33
Act: $0.37
+12.9%
Q3
✓ Beat
Est: $0.36
Act: $0.44
+20.5%
Q2
✓ Beat
Est: $0.32
Act: $0.33
+3.5%
Q1
✓ Beat
Est: $0.45
Act: $0.50
+10.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

11.6
Forward P/E
PEG Ratio
1.02
Price/Book
2M
Avg Volume
$21.35
52W High
$14.87
52W Low
52W Range Position

TGNA Capital Efficiency

How efficiently does TGNA convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$283M
EBITDA
$544M
FCF Conversion
52%
Reinvestment Rate
48%
52% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
5.5%
ROIC − WACC Spread
-0.7%

TGNA converts 52% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. However, the ROIC-WACC spread is negative (-0.7%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-03-23851$20.03$17,045.53
2026-03-10100$20.91$2,091
2026-03-05325,000$20.95$6.8M
2026-03-04316$20.93$6,613.88
2026-02-274,560$21.05$95,988
2026-02-25664$20.90$13,877.6
2026-02-123$20.79$62.37
2026-02-0292$19.16$1,762.72
2026-01-292,008$18.85$37,850.8
2026-01-151,017$18.91$19,231.47
2026-01-0956$19.08$1,068.48
2025-12-222,756$19.31$53,218.36
2025-12-0845$19.16$862.2
2025-12-0545$19.27$867.15
2025-12-0311$19.35$212.85
2025-11-104,233$19.95$84,448.35
2025-11-0746$19.84$912.64
2025-11-065,755$19.93$114,697.15
2025-10-288,521$19.84$169,056.64
2025-10-06337,381$20.12$6.8M
2025-10-0323,050$20.30$467,915
2025-10-02442,075$20.30$9.0M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare TGNA to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.